Labetuzumab Govitecan Biosimilar - Research Grade,ichor.bio,ICH5617G

Host

CHO Cells

Reactivity

Human

Platform ID

BAB511975956

ichor.bio

Headquarters

Grove Business Park Downsview Road Wantage OX12 9FF

Contact

Tel:
Fax:

Product Specifications
Scientific Background
Synonyms

Specifications

NameLabetuzumab Govitecan Biosimilar - Research Grade
Cat. No.ICH5617G
HostCHO Cells
IsotypeIgG1
ReactivityHuman
Concentration1mg/ml
TargetCEACAM5 / CEA / CD66e
Purity>90% by SDS-PAGE
ShippingRoom Temp
StorageThis biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.
Regulatory StatusFor research use only

Scientific Background

Labetuzumab Govitecan is an antibody-drug conjugate (ADC) containing labetuzumab, a mildly reduced, anti-CEACAM5 humanized monoclonal antibody, conjugated to the potent topoisomerase I inhibitor SN-38, with antineoplastic activity.

Synonyms

SN38

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.